Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Delattre, O."" wg kryterium: Wszystkie pola


Tytuł :
The usefulness of a short stay geriatric unit post emergency department for the facilitation of in-hospital care of elderly subjects.
Autorzy :
Moyet J; Departments of Geriatric Medicine.
Douay B; Emergency.
Delattre O; Departments of Geriatric Medicine.
Hannat S; Departments of Geriatric Medicine.
Defouilloy C; Departments of Geriatric Medicine.
Bloch F; Departments of Geriatric Medicine.; Laboratory of Functional Neurosciences EA 4559, University Hospital of Amiens-Picardie, Amiens, France.
Pokaż więcej
Źródło :
European journal of emergency medicine : official journal of the European Society for Emergency Medicine [Eur J Emerg Med] 2020 Jun; Vol. 27 (3), pp. 230-231.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 9442482 Publication Model: Print Cited Medium: Internet ISSN: 1473-5695 (Electronic) Linking ISSN: 09699546 NLM ISO Abbreviation: Eur J Emerg Med Subsets: In Process; MEDLINE
Czasopismo naukowe
Tytuł :
Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid tumors.
Autorzy :
Theruvath J; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.
Sotillo E; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.
Mount CW; Department of Neurology, Stanford University School of Medicine, Stanford, CA, USA.
Graef CM; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.
Delaidelli A; Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.
Heitzeneder S; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.
Labanieh L; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.; Department of Bioengineering, Stanford University, Stanford, CA, USA.
Dhingra S; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.
Leruste A; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.
Majzner RG; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
Xu P; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.
Mueller S; Department of Neurology, University of California San Francisco, San Francisco, CA, USA.; Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.; Department of Pediatrics, University of California San Francisco, San Francisco, CA, USA.
Yecies DW; Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA, USA.
Finetti MA; Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK.
Williamson D; Wolfson Childhood Cancer Research Centre, Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK.
Johann PD; Hopp Children's Cancer Center Heidelberg, Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center and German Cancer Consortium, Heidelberg, Germany.; Department of Pediatric Hematology and Oncology, Heidelberg University Hospital, Heidelberg, Germany.
Kool M; Hopp Children's Cancer Center Heidelberg, Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center and German Cancer Consortium, Heidelberg, Germany.
Pfister S; Hopp Children's Cancer Center Heidelberg, Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center and German Cancer Consortium, Heidelberg, Germany.; Department of Pediatric Hematology and Oncology, Heidelberg University Hospital, Heidelberg, Germany.
Hasselblatt M; Institute of Neuropathology, Münster University Hospital, Münster, Germany.
Frühwald MC; University Children's Hospital Augsburg, Swabian Children's Cancer Center, Augsburg, Germany.; EU-RHAB Registry Center, Augsburg, Germany.
Delattre O; Paris Sciences Lettres Research University, INSERM U830, Paris, France.; Paris Sciences Lettres Research University, SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France.
Surdez D; Paris Sciences Lettres Research University, INSERM U830, Paris, France.; Paris Sciences Lettres Research University, SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France.
Bourdeaut F; Paris Sciences Lettres Research University, INSERM U830, Paris, France.; Paris Sciences Lettres Research University, SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France.
Puget S; Paris University, Necker-Enfants Malades Hospital, Department of Neurosurgery, Assistance Publique-Hôpitaux de Paris, Paris, France.
Zaidi S; Paris Sciences Lettres Research University, INSERM U830, Paris, France.; Paris Sciences Lettres Research University, SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France.
Mitra SS; Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Cheshier S; Division of Pediatric Neurosurgery, Department of Neurosurgery, Primary Children's Hospital and Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
Sorensen PH; Department of Molecular Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada.
Monje M; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.; Department of Neurology, Stanford University School of Medicine, Stanford, CA, USA.; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA, USA.; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.; Stanford Institute for Stem Cell and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Mackall CL; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA. .; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. .; Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA. .
Pokaż więcej
Źródło :
Nature medicine [Nat Med] 2020 May; Vol. 26 (5), pp. 712-719. Date of Electronic Publication: 2020 Apr 27.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat. Med. Subsets: In Process; MEDLINE
Czasopismo naukowe
Tytuł :
Hyperréduction après brochage des fractures de l’extrémité distale du radius chez le sujet jeune actif. Prévention par brochage mixte multiple
Alternatywny tytuł :
Over-reduction after distal radius fracture pinning in young active patients: Prevention by multiple mixed pinning (English)
Autorzy :
Delattre, O.
Greffe, G.
Stratan, L.
Duroux, F.
Donatien, J.
Pokaż więcej
Źródło :
In Fractures de l'extremite distale du radius, Hand Surgery and Rehabilitation December 2016 35 Supplement:S89-S94
Czasopismo naukowe
Tytuł :
ZRANB2 and SYF2-mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin.
Autorzy :
Tanaka I; Institut Curie, PSL Research University, CNRS UMR 3348, F-91405 Orsay, France.; Paris Sud University, Paris-Saclay University, CNRS UMR 3348, F-91405 Orsay, France.; Equipe Labellisée Ligue Contre le Cancer.
Chakraborty A; Institut Curie, PSL Research University, CNRS UMR 3348, F-91405 Orsay, France.; Paris Sud University, Paris-Saclay University, CNRS UMR 3348, F-91405 Orsay, France.; Equipe Labellisée Ligue Contre le Cancer.
Saulnier O; Institut Curie Research Center, SIREDO Oncology Center, Paris-Sciences-Lettres Research University, INSERM U830, Laboratory of Biology and Genetics of Cancers, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, France.
Benoit-Pilven C; CNRS UMR 5239, Ecole Normale Supérieure de Lyon, Lyon, France.
Vacher S; Unité de Pharmacogénomique, Service de génétique, Institut Curie, Paris, France; Université Paris Descartes, Paris, France.
Labiod D; Paris Sud University, Paris-Saclay University, CNRS UMR 3348, F-91405 Orsay, France.; Institut Curie, PSL Research University, Translational Research Department, Experimental Radiotherapy Platform, Orsay, France.
Lam EWF; Imperial College London, London, UK.
Bièche I; Unité de Pharmacogénomique, Service de génétique, Institut Curie, Paris, France; Université Paris Descartes, Paris, France.
Delattre O; Institut Curie Research Center, SIREDO Oncology Center, Paris-Sciences-Lettres Research University, INSERM U830, Laboratory of Biology and Genetics of Cancers, Paris, France; Université Paris Diderot, Sorbonne Paris Cité, France.
Pouzoulet F; Paris Sud University, Paris-Saclay University, CNRS UMR 3348, F-91405 Orsay, France.; Institut Curie, PSL Research University, Translational Research Department, Experimental Radiotherapy Platform, Orsay, France.
Auboeuf D; CNRS UMR 5239, Ecole Normale Supérieure de Lyon, Lyon, France.
Vagner S; Institut Curie, PSL Research University, CNRS UMR 3348, F-91405 Orsay, France.; Paris Sud University, Paris-Saclay University, CNRS UMR 3348, F-91405 Orsay, France.; Equipe Labellisée Ligue Contre le Cancer.
Dutertre M; Institut Curie, PSL Research University, CNRS UMR 3348, F-91405 Orsay, France.; Paris Sud University, Paris-Saclay University, CNRS UMR 3348, F-91405 Orsay, France.; Equipe Labellisée Ligue Contre le Cancer.
Pokaż więcej
Źródło :
Nucleic acids research [Nucleic Acids Res] 2020 Mar 18; Vol. 48 (5), pp. 2676-2693.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Journal Info :
Publisher: Oxford University Press Country of Publication: England NLM ID: 0411011 Publication Model: Print Cited Medium: Internet ISSN: 1362-4962 (Electronic) Linking ISSN: 03051048 NLM ISO Abbreviation: Nucleic Acids Res. Subsets: MEDLINE
MeSH Terms :
Drug Resistance, Neoplasm*/drug effects
Drug Resistance, Neoplasm*/genetics
Alternative Splicing/*genetics
Breast Neoplasms/*drug therapy
Doxorubicin/*therapeutic use
Proto-Oncogene Proteins/*metabolism
RNA-Binding Proteins/*metabolism
Adult ; Aged ; Aged, 80 and over ; Alternative Splicing/drug effects ; Animals ; Breast Neoplasms/genetics ; Breast Neoplasms/pathology ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Doxorubicin/pharmacology ; Epithelial-Mesenchymal Transition/drug effects ; Epithelial-Mesenchymal Transition/genetics ; Exons/genetics ; Female ; Gene Expression Regulation, Neoplastic/drug effects ; Humans ; MCF-7 Cells ; Mice, Nude ; MicroRNAs/genetics ; MicroRNAs/metabolism ; Middle Aged ; Protein Isoforms/metabolism ; RNA Splice Sites/genetics ; S Phase/drug effects ; Spliceosomes/metabolism
Czasopismo naukowe
Tytuł :
High Specificity of BCL11B and GLG1 for EWSR1-FLI1 and EWSR1-ERG Positive Ewing Sarcoma.
Autorzy :
Orth MF; Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, Faculty of Medicine, LMU Munich, 80337 Munich, Germany.
Hölting TLB; Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, Faculty of Medicine, LMU Munich, 80337 Munich, Germany.
Dallmayer M; Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, Faculty of Medicine, LMU Munich, 80337 Munich, Germany.; Department of Pediatrics, University Hospital Münster, 48149 Münster, Germany.
Wehweck FS; Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, Faculty of Medicine, LMU Munich, 80337 Munich, Germany.; Institute of Pathology, Faculty of Medicine, LMU Munich, 80337 Munich, Germany.
Paul T; Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, Faculty of Medicine, LMU Munich, 80337 Munich, Germany.; Institute of Pathology, Faculty of Medicine, LMU Munich, 80337 Munich, Germany.
Musa J; Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, Faculty of Medicine, LMU Munich, 80337 Munich, Germany.; Department of General, Visceral and Transplantation Surgery, University of Heidelberg, 69120 Heidelberg, Germany.
Baldauf MC; Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, Faculty of Medicine, LMU Munich, 80337 Munich, Germany.
Surdez D; INSERM Unit 830 'Genetics and Biology of Cancers', Institut Curie Research Center, 75248 Paris, France.
Delattre O; INSERM Unit 830 'Genetics and Biology of Cancers', Institut Curie Research Center, 75248 Paris, France.
Knott MML; Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, Faculty of Medicine, LMU Munich, 80337 Munich, Germany.; Institute of Pathology, Faculty of Medicine, LMU Munich, 80337 Munich, Germany.
Romero-Pérez L; Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, Faculty of Medicine, LMU Munich, 80337 Munich, Germany.
Kasan M; Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, Faculty of Medicine, LMU Munich, 80337 Munich, Germany.
Cidre-Aranaz F; Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, Faculty of Medicine, LMU Munich, 80337 Munich, Germany.
Gerke JS; Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, Faculty of Medicine, LMU Munich, 80337 Munich, Germany.
Ohmura S; Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, Faculty of Medicine, LMU Munich, 80337 Munich, Germany.
Li J; Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, Faculty of Medicine, LMU Munich, 80337 Munich, Germany.
Marchetto A; Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, Faculty of Medicine, LMU Munich, 80337 Munich, Germany.
Henssen AG; Department of Pediatric Hematology/Oncology/BMT, Charité-University Medicine Berlin, 13353 Berlin, Germany.; Experimental and Clinical Research Center (ECRC) of the MDC and Charité Berlin, 13125 Berlin, Germany.
Özen Ö; Department of Pathology, Başkent University Hospital, 06490 Ankara, Turkey.
Sugita S; Department of Surgical Pathology, Sapporo Medical University, 060-8556 Sapporo, Japan.
Hasegawa T; Department of Surgical Pathology, Sapporo Medical University, 060-8556 Sapporo, Japan.
Kanaseki T; Department of Pathology, Sapporo Medical University, 060-8556 Sapporo, Japan.
Bertram S; Institute of Pathology, University Hospital Essen, 45147 Essen, Germany.
Dirksen U; Pediatrics III, AYA Unit, West German Cancer Centre, University Hospital Essen, 45147 Essen, Germany.; German Cancer Consortium (DKTK), Partner site Essen, 45147 Essen, Germany.
Hartmann W; Division of Translational Oncology, Gerhard-Domagk-Institute for Pathology, University Hospital Münster, 48149 Münster, Germany.
Kirchner T; Institute of Pathology, Faculty of Medicine, LMU Munich, 80337 Munich, Germany.; German Cancer Consortium (DKTK), Partner site Munich, 80336 Munich, Germany.; German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Grünewald TGP; Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, Faculty of Medicine, LMU Munich, 80337 Munich, Germany.; Institute of Pathology, Faculty of Medicine, LMU Munich, 80337 Munich, Germany.; German Cancer Consortium (DKTK), Partner site Munich, 80336 Munich, Germany.; German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Pokaż więcej
Źródło :
Cancers [Cancers (Basel)] 2020 Mar 10; Vol. 12 (3). Date of Electronic Publication: 2020 Mar 10.
Typ publikacji :
Journal Article
Journal Info :
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Czasopismo naukowe
Tytuł :
High CD44 expression is not a prognosis marker in patients with high-risk neuroblastoma.
Autorzy :
Louis-Brennetot C; Inserm U830, Institut Curie, PSL Research University, Equipe Labellisée Ligue contre le Cancer, Paris F-75005, France.
Delattre O; Inserm U830, Institut Curie, PSL Research University, Equipe Labellisée Ligue contre le Cancer, Paris F-75005, France.
Janoueix-Lerosey I; Inserm U830, Institut Curie, PSL Research University, Equipe Labellisée Ligue contre le Cancer, Paris F-75005, France. Electronic address: .
Pokaż więcej
Źródło :
EBioMedicine [EBioMedicine] 2020 Mar; Vol. 53, pp. 102702. Date of Electronic Publication: 2020 Mar 19.
Typ publikacji :
Journal Article; Comment
Journal Info :
Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3964 (Electronic) Linking ISSN: 23523964 NLM ISO Abbreviation: EBioMedicine Subsets: MEDLINE
MeSH Terms :
Neural Crest*
Neuroblastoma*
Humans ; Hyaluronan Receptors ; Prognosis
Czasopismo naukowe
Tytuł :
Aurora A Kinase Inhibition Destabilizes PAX3-FOXO1 and MYCN and Synergizes with Navitoclax to Induce Rhabdomyosarcoma Cell Death.
Autorzy :
Ommer J; Department of Oncology and Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland.
Selfe JL; Sarcoma Molecular Pathology Laboratory, The Institute of Cancer Research, London, United Kingdom.
Wachtel M; Department of Oncology and Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland.
O'Brien EM; Sarcoma Molecular Pathology Laboratory, The Institute of Cancer Research, London, United Kingdom.
Laubscher D; Department of Oncology and Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland.
Roemmele M; Department of Oncology and Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland.
Kasper S; Department of Oncology and Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland.
Delattre O; France INSERM U830, Équipe Labellisé LNCC, PSL Université, SIREDO Oncology Centre, Institut Curie, Paris, France.
Surdez D; France INSERM U830, Équipe Labellisé LNCC, PSL Université, SIREDO Oncology Centre, Institut Curie, Paris, France.
Petts G; Department of Diagnostic Paediatric Histopathology, Royal Manchester Children's Hospital, Manchester, United Kingdom.
Kelsey A; Department of Diagnostic Paediatric Histopathology, Royal Manchester Children's Hospital, Manchester, United Kingdom.
Shipley J; Sarcoma Molecular Pathology Laboratory, The Institute of Cancer Research, London, United Kingdom.
Schäfer BW; Department of Oncology and Children's Research Center, University Children's Hospital Zurich, Zurich, Switzerland. .
Pokaż więcej
Źródło :
Cancer research [Cancer Res] 2020 Feb 15; Vol. 80 (4), pp. 832-842. Date of Electronic Publication: 2019 Dec 30.
Typ publikacji :
Journal Article
Journal Info :
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res. Subsets: In Process; MEDLINE
Czasopismo naukowe
Tytuł :
Transcriptional Programs Define Intratumoral Heterogeneity of Ewing Sarcoma at Single-Cell Resolution.
Autorzy :
Aynaud MM; INSERM U830, Équipe Labellisée LNCC, SIREDO Oncology Centre, Institut Curie, 75005 Paris, France.
Mirabeau O; INSERM U830, Équipe Labellisée LNCC, SIREDO Oncology Centre, Institut Curie, 75005 Paris, France.
Gruel N; INSERM U830, Équipe Labellisée LNCC, SIREDO Oncology Centre, Institut Curie, 75005 Paris, France; Institut Curie, PSL Research University, Department of Translational Research, 75005 Paris, France.
Grossetête S; INSERM U830, Équipe Labellisée LNCC, SIREDO Oncology Centre, Institut Curie, 75005 Paris, France.
Boeva V; Institut Cochin, INSERM U1016, CNRS UMR 8104, Université Paris Descartes UMR-S1016, 75014 Paris, France; Department of Computer Science, Institute for Machine Learning, Swiss Institute of Bioinformatics (SIB), ETH Zurich, 8092 Zurich, Switzerland; INSERM U900, 75005 Paris, France; Mines ParisTech, PSL Research University, CBIO-Centre for Computational Biology, 75006 Paris, France; Institut Curie, PSL Research University, 75005 Paris, France.
Durand S; INSERM U830, Équipe Labellisée LNCC, SIREDO Oncology Centre, Institut Curie, 75005 Paris, France.
Surdez D; INSERM U830, Équipe Labellisée LNCC, SIREDO Oncology Centre, Institut Curie, 75005 Paris, France.
Saulnier O; INSERM U830, Équipe Labellisée LNCC, SIREDO Oncology Centre, Institut Curie, 75005 Paris, France.
Zaïdi S; INSERM U830, Équipe Labellisée LNCC, SIREDO Oncology Centre, Institut Curie, 75005 Paris, France.
Gribkova S; INSERM U900, 75005 Paris, France; Mines ParisTech, PSL Research University, CBIO-Centre for Computational Biology, 75006 Paris, France; Institut Curie, PSL Research University, 75005 Paris, France; Université Denis Diderot, 75013, Paris, France.
Fouché A; École Normale Supérieure Paris-Saclay, 94230 Cachan, France.
Kairov U; Laboratory of Bioinformatics and Systems Biology, Center for Life Sciences, National Laboratory Astana, Nazarbayev University, Nur-Sultan, Kazakhstan.
Raynal V; INSERM U830, Équipe Labellisée LNCC, SIREDO Oncology Centre, Institut Curie, 75005 Paris, France.
Tirode F; University of Lyon, Université Claude Bernard Lyon 1, CNRS 5286, INSERM U1052, Cancer Research Centre of Lyon, 69008 Lyon, France.
Grünewald TGP; INSERM U830, Équipe Labellisée LNCC, SIREDO Oncology Centre, Institut Curie, 75005 Paris, France; Institut Curie, PSL Research University, Department of Translational Research, 75005 Paris, France.
Bohec M; NGS Platform, Institut Curie, 75005 Paris, France.
Baulande S; NGS Platform, Institut Curie, 75005 Paris, France.
Janoueix-Lerosey I; INSERM U830, Équipe Labellisée LNCC, SIREDO Oncology Centre, Institut Curie, 75005 Paris, France.
Vert JP; Mines ParisTech, PSL Research University, CBIO-Centre for Computational Biology, 75006 Paris, France; Google Research, Brain Team, 75009 Paris, France.
Barillot E; INSERM U900, 75005 Paris, France; Mines ParisTech, PSL Research University, CBIO-Centre for Computational Biology, 75006 Paris, France; Institut Curie, PSL Research University, 75005 Paris, France.
Delattre O; INSERM U830, Équipe Labellisée LNCC, SIREDO Oncology Centre, Institut Curie, 75005 Paris, France. Electronic address: olivier.delattre@curie.fr.
Zinovyev A; INSERM U900, 75005 Paris, France; Mines ParisTech, PSL Research University, CBIO-Centre for Computational Biology, 75006 Paris, France; Institut Curie, PSL Research University, 75005 Paris, France. Electronic address: .
Pokaż więcej
Źródło :
Cell reports [Cell Rep] 2020 Feb 11; Vol. 30 (6), pp. 1767-1779.e6.
Typ publikacji :
Journal Article
Journal Info :
Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: In Process; MEDLINE
Czasopismo naukowe
Tytuł :
Association of Partial Chromosome 3 Deletion in Uveal Melanomas With Metastasis-Free Survival.
Autorzy :
Rodrigues M; Unit 830 (Cancer, Heterogeneity, Instability and Plasticity) INSERM, Institut Curie, PSL Research University, Paris, France.; Department of Medical Oncology, Institut Curie, PSL Research University, Paris, France.
Ait Rais K; Department of Genetics, Institut Curie, PSL Research University, Paris, France.
Salviat F; Department of Biometry, Institut Curie, PSL Research University, Paris, France.
Algret N; Department of Biometry, Institut Curie, PSL Research University, Paris, France.
Simaga F; Department of Genetics, Institut Curie, PSL Research University, Paris, France.
Barnhill R; Department of Biopathology, Institut Curie, PSL Research University, Paris, France.; Faculty of Medicine, University of Paris Descartes, Paris, France.
Gardrat S; Unit 830 (Cancer, Heterogeneity, Instability and Plasticity) INSERM, Institut Curie, PSL Research University, Paris, France.; Department of Biopathology, Institut Curie, PSL Research University, Paris, France.
Servois V; Department of Medical Imaging, Institut Curie, PSL Research University, Paris, France.
Mariani P; Department of Surgical Oncology, Institut Curie, PSL Research University, Paris, France.
Piperno-Neumann S; Department of Medical Oncology, Institut Curie, PSL Research University, Paris, France.
Roman-Roman S; Department of Translational Research, Institut Curie, PSL Research University, Paris, France.
Delattre O; Unit 830 (Cancer, Heterogeneity, Instability and Plasticity) INSERM, Institut Curie, PSL Research University, Paris, France.; Department of Genetics, Institut Curie, PSL Research University, Paris, France.
Cassoux N; Faculty of Medicine, University of Paris Descartes, Paris, France.; Department of Ocular Oncology, Institut Curie, PSL Research University, Paris, France.
Savignoni A; Department of Biometry, Institut Curie, PSL Research University, Paris, France.
Stern MH; Unit 830 (Cancer, Heterogeneity, Instability and Plasticity) INSERM, Institut Curie, PSL Research University, Paris, France.; Department of Genetics, Institut Curie, PSL Research University, Paris, France.
Pierron G; Department of Genetics, Institut Curie, PSL Research University, Paris, France.
Pokaż więcej
Źródło :
JAMA ophthalmology [JAMA Ophthalmol] 2020 Jan 02. Date of Electronic Publication: 2020 Jan 02.
Typ publikacji :
Journal Article
Journal Info :
Publisher: American Medical Association Country of Publication: United States NLM ID: 101589539 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2168-6173 (Electronic) Linking ISSN: 21686165 NLM ISO Abbreviation: JAMA Ophthalmol Subsets: Core Clinical (AIM); MEDLINE
Czasopismo naukowe
Tytuł :
Clonally Expanded T Cells Reveal Immunogenicity of Rhabdoid Tumors.
Autorzy :
Leruste A; PSL Research University, Institut Curie Research Center, INSERM U830, Paris, France; PSL Research University, Institut Curie Research Center, Translational Research Department, Paris, France; SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France.
Tosello J; PSL Research University, Institut Curie Research Center, Translational Research Department, Paris, France; PSL Research University, Institut Curie Research Center, INSERM U932, Paris, France.
Ramos RN; PSL Research University, Institut Curie Research Center, Translational Research Department, Paris, France; PSL Research University, Institut Curie Research Center, INSERM U932, Paris, France.
Tauziède-Espariat A; Sainte-Anne Hospital, Department of Neuropathology, Paris, France.
Brohard S; PSL Research University, Institut Curie Research Center, Translational Research Department, Paris, France; SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France.
Han ZY; PSL Research University, Institut Curie Research Center, INSERM U830, Paris, France; PSL Research University, Institut Curie Research Center, Translational Research Department, Paris, France; SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France.
Beccaria K; AP-HP, Necker Hospital, Department of Neurosurgery, Paris, France.
Andrianteranagna M; PSL Research University, Institut Curie Research Center, INSERM U900, Paris, France; MINES ParisTech, PSL Research University, CBIO-Centre for Computational Biology, Paris, France.
Caudana P; PSL Research University, Institut Curie Research Center, Translational Research Department, Paris, France; PSL Research University, Institut Curie Research Center, INSERM U932, Paris, France.
Nikolic J; PSL Research University, Institut Curie Research Center, INSERM U932, Paris, France.
Chauvin C; PSL Research University, Institut Curie Research Center, INSERM U830, Paris, France; PSL Research University, Institut Curie Research Center, Translational Research Department, Paris, France; SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France.
Niborski LL; PSL Research University, Institut Curie Research Center, Translational Research Department, Paris, France; PSL Research University, Institut Curie Research Center, INSERM U932, Paris, France.
Manriquez V; PSL Research University, Institut Curie Research Center, Translational Research Department, Paris, France; PSL Research University, Institut Curie Research Center, INSERM U932, Paris, France.
Richer W; PSL Research University, Institut Curie Research Center, Translational Research Department, Paris, France; PSL Research University, Institut Curie Research Center, INSERM U932, Paris, France.
Masliah-Planchon J; PSL Research University, Institut Curie Hospital, Laboratory of Somatic Genetics, Paris, France.
Grossetête-Lalami S; PSL Research University, Institut Curie Research Center, INSERM U830, Paris, France; SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France.
Bohec M; PSL Research University, Institut Curie Genomics of Excellence (ICGex) Platform, Paris, France.
Lameiras S; PSL Research University, Institut Curie Genomics of Excellence (ICGex) Platform, Paris, France.
Baulande S; PSL Research University, Institut Curie Genomics of Excellence (ICGex) Platform, Paris, France.
Pouponnot C; PSL Research University, Institut Curie Research Center, CNRS UMR 3347, INSERM U1021, Orsay, France.
Coulomb A; AP-HP, Armand Trousseau Hospital, Department of Pathology, Paris, France.
Galmiche L; AP-HP, Necker Hospital, Department of Pathology, Paris, France.
Surdez D; PSL Research University, Institut Curie Research Center, INSERM U830, Paris, France; SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France.
Servant N; PSL Research University, Institut Curie Research Center, INSERM U900, Paris, France; MINES ParisTech, PSL Research University, CBIO-Centre for Computational Biology, Paris, France.
Helft J; PSL Research University, Institut Curie Research Center, Translational Research Department, Paris, France; PSL Research University, Institut Curie Research Center, INSERM U932, Paris, France.
Sedlik C; PSL Research University, Institut Curie Research Center, Translational Research Department, Paris, France; PSL Research University, Institut Curie Research Center, INSERM U932, Paris, France.
Puget S; AP-HP, Necker Hospital, Department of Neurosurgery, Paris, France.
Benaroch P; PSL Research University, Institut Curie Research Center, INSERM U932, Paris, France.
Delattre O; PSL Research University, Institut Curie Research Center, INSERM U830, Paris, France; SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France.
Waterfall JJ; PSL Research University, Institut Curie Research Center, INSERM U830, Paris, France; PSL Research University, Institut Curie Research Center, Translational Research Department, Paris, France. Electronic address: .
Piaggio E; PSL Research University, Institut Curie Research Center, Translational Research Department, Paris, France; PSL Research University, Institut Curie Research Center, INSERM U932, Paris, France. Electronic address: .
Bourdeaut F; PSL Research University, Institut Curie Research Center, INSERM U830, Paris, France; PSL Research University, Institut Curie Research Center, Translational Research Department, Paris, France; SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France. Electronic address: .
Pokaż więcej
Źródło :
Cancer cell [Cancer Cell] 2019 Dec 09; Vol. 36 (6), pp. 597-612.e8. Date of Electronic Publication: 2019 Nov 07.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Journal Info :
Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE
MeSH Terms :
Chromatin Assembly and Disassembly/*immunology
Rhabdoid Tumor/*genetics
Rhabdoid Tumor/*immunology
T-Lymphocytes/*immunology
Animals ; Chromosomal Proteins, Non-Histone/genetics ; Chromosomal Proteins, Non-Histone/immunology ; DNA-Binding Proteins/genetics ; DNA-Binding Proteins/immunology ; Humans ; Immunohistochemistry/methods ; Mice, Inbred C57BL ; Mice, Transgenic ; Mutation/genetics ; Nuclear Proteins/genetics ; Transcription Factors/genetics ; Transcription Factors/immunology
Czasopismo naukowe
Tytuł :
Class I HDAC inhibitors enhance YB-1 acetylation and oxidative stress to block sarcoma metastasis.
Autorzy :
El-Naggar AM; Department of Pathology & Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.; Department of Molecular Oncology, BC Cancer, part of the Provincial Health Services Authority, Vancouver, BC, Canada.; Department of Pathology, Faculty of Medicine, Menoufia University, Shibin El Kom, Egypt.
Somasekharan SP; Vancouver Prostate Centre, Vancouver, BC, Canada.
Wang Y; Department of Molecular Oncology, BC Cancer, part of the Provincial Health Services Authority, Vancouver, BC, Canada.
Cheng H; Vancouver Prostate Centre, Vancouver, BC, Canada.
Negri GL; Michael Smith Genome Sciences Centre, Vancouver, BC, Canada.
Pan M; Department of Molecular Oncology, BC Cancer, part of the Provincial Health Services Authority, Vancouver, BC, Canada.
Wang XQ; Department of Molecular Oncology, BC Cancer, part of the Provincial Health Services Authority, Vancouver, BC, Canada.
Delaidelli A; Department of Pathology & Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.; Department of Molecular Oncology, BC Cancer, part of the Provincial Health Services Authority, Vancouver, BC, Canada.
Rafn B; Department of Molecular Oncology, BC Cancer, part of the Provincial Health Services Authority, Vancouver, BC, Canada.
Cran J; Department of Molecular Oncology, BC Cancer, part of the Provincial Health Services Authority, Vancouver, BC, Canada.
Zhang F; Vancouver Prostate Centre, Vancouver, BC, Canada.
Zhang H; Department of Pathology & Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.; Department of Molecular Oncology, BC Cancer, part of the Provincial Health Services Authority, Vancouver, BC, Canada.
Colborne S; Michael Smith Genome Sciences Centre, Vancouver, BC, Canada.
Gleave M; Vancouver Prostate Centre, Vancouver, BC, Canada.
Mandinova A; Brigham and Women's Hospital, Harvard University, Boston, MA, USA.
Kedersha N; Massachusetts General Hospital, Harvard University, Boston, MA, USA.
Hughes CS; Department of Molecular Oncology, BC Cancer, part of the Provincial Health Services Authority, Vancouver, BC, Canada.
Surdez D; Centre de recherche de l'Institut Curie, Paris, France.
Delattre O; Centre de recherche de l'Institut Curie, Paris, France.
Wang Y; Vancouver Prostate Centre, Vancouver, BC, Canada.
Huntsman DG; Department of Pathology & Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.; Department of Molecular Oncology, BC Cancer, part of the Provincial Health Services Authority, Vancouver, BC, Canada.
Morin GB; Michael Smith Genome Sciences Centre, Vancouver, BC, Canada.
Sorensen PH; Department of Pathology & Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.; Department of Molecular Oncology, BC Cancer, part of the Provincial Health Services Authority, Vancouver, BC, Canada.
Pokaż więcej
Źródło :
EMBO reports [EMBO Rep] 2019 Dec 05; Vol. 20 (12), pp. e48375. Date of Electronic Publication: 2019 Oct 31.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Journal Info :
Publisher: Wiley Blackwell Country of Publication: England NLM ID: 100963049 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1469-3178 (Electronic) Linking ISSN: 1469221X NLM ISO Abbreviation: EMBO Rep. Subsets: MEDLINE
MeSH Terms :
Antineoplastic Agents/*therapeutic use
Benzamides/*therapeutic use
Bone Neoplasms/*drug therapy
Histone Deacetylase Inhibitors/*therapeutic use
Pyridines/*therapeutic use
Sarcoma, Ewing/*drug therapy
Transcription Factors/*metabolism
Acetylation ; Animals ; Bone Neoplasms/metabolism ; Bone Neoplasms/pathology ; Cell Line, Tumor ; Cells, Cultured ; Humans ; Hypoxia-Inducible Factor 1, alpha Subunit/metabolism ; Mice ; NF-E2-Related Factor 2/metabolism ; Neoplasm Metastasis ; Oxidative Stress ; Sarcoma, Ewing/metabolism ; Sarcoma, Ewing/pathology
Czasopismo naukowe
Tytuł :
Study of chromatin remodeling genes implicates SMARCA4 as a putative player in oncogenesis in neuroblastoma.
Autorzy :
Bellini A; Equipe SiRIC RTOP Recherche Translationelle en Oncologie Pédiatrique, Institut Curie, Paris, France.; INSERM U830, Laboratoire de Génétique et Biologie des Cancers, Institut Curie, Paris, France.; SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France.
Bessoltane-Bentahar N; Equipe SiRIC RTOP Recherche Translationelle en Oncologie Pédiatrique, Institut Curie, Paris, France.; INSERM U830, Laboratoire de Génétique et Biologie des Cancers, Institut Curie, Paris, France.; SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France.
Bhalshankar J; Equipe SiRIC RTOP Recherche Translationelle en Oncologie Pédiatrique, Institut Curie, Paris, France.; INSERM U830, Laboratoire de Génétique et Biologie des Cancers, Institut Curie, Paris, France.; SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France.
Clement N; Equipe SiRIC RTOP Recherche Translationelle en Oncologie Pédiatrique, Institut Curie, Paris, France.; INSERM U830, Laboratoire de Génétique et Biologie des Cancers, Institut Curie, Paris, France.; SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France.
Raynal V; Institut Curie, PSL Research University, Inserm U830, Equipe Labellisée Ligue contre le Cancer, Paris, France.; Plateforme de Séquençage ICGex, Institut Curie, Paris, France.
Baulande S; Institut Curie, PSL Research University, NGS Platform, Paris, France.
Bernard V; Department of Biopathology, Institut Curie, PSL Research University, Paris, France.
Danzon A; Equipe SiRIC RTOP Recherche Translationelle en Oncologie Pédiatrique, Institut Curie, Paris, France.; INSERM U830, Laboratoire de Génétique et Biologie des Cancers, Institut Curie, Paris, France.; SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France.
Chicard M; Equipe SiRIC RTOP Recherche Translationelle en Oncologie Pédiatrique, Institut Curie, Paris, France.; INSERM U830, Laboratoire de Génétique et Biologie des Cancers, Institut Curie, Paris, France.; SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France.
Colmet-Daage L; Equipe SiRIC RTOP Recherche Translationelle en Oncologie Pédiatrique, Institut Curie, Paris, France.; INSERM U830, Laboratoire de Génétique et Biologie des Cancers, Institut Curie, Paris, France.; SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France.
Pierron G; Unité de Génétique Somatique, Institut Curie, Paris, France.
Le Roux L; Unité de Génétique Somatique, Institut Curie, Paris, France.
Planchon JM; SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France.; Department of Biopathology, Institut Curie, PSL Research University, Paris, France.
Combaret V; Laboratoire de Recherche Translationnelle, Centre Léon-Bérard, Lyon, France.
Lapouble E; SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France.; Unité de Génétique Somatique, Institut Curie, Paris, France.
Corradini N; Institut d'Hématologie et Oncologie Pédiatrique, Lyon, France.
Thebaud E; Service d'Oncologie Pédiatrique, Hôpital de la Mère et l'enfant, Nantes, France.
Gambart M; Unite d'Hemato-Oncologie, Hôpital des Enfants, Toulouse, France.
Valteau-Couanet D; Service d'Oncologie Pédiatrique, Institut Gustave Roussy, Paris, France.
Michon J; SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France.
Louis-Brennetot C; INSERM U830, Laboratoire de Génétique et Biologie des Cancers, Institut Curie, Paris, France.; SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France.; Institut Curie, PSL Research University, Inserm U830, Equipe Labellisée Ligue contre le Cancer, Paris, France.
Janoueix-Lerosey I; INSERM U830, Laboratoire de Génétique et Biologie des Cancers, Institut Curie, Paris, France.; SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France.; Institut Curie, PSL Research University, Inserm U830, Equipe Labellisée Ligue contre le Cancer, Paris, France.
Defachelles AS; Pediatric Oncology Unit, AntiCancer Center Oscar Lambret, Lille, France.
Bourdeaut F; Equipe SiRIC RTOP Recherche Translationelle en Oncologie Pédiatrique, Institut Curie, Paris, France.; INSERM U830, Laboratoire de Génétique et Biologie des Cancers, Institut Curie, Paris, France.; SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France.
Delattre O; INSERM U830, Laboratoire de Génétique et Biologie des Cancers, Institut Curie, Paris, France.; SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France.; Institut Curie, PSL Research University, Inserm U830, Equipe Labellisée Ligue contre le Cancer, Paris, France.; Unité de Génétique Somatique, Institut Curie, Paris, France.
Schleiermacher G; Equipe SiRIC RTOP Recherche Translationelle en Oncologie Pédiatrique, Institut Curie, Paris, France.; INSERM U830, Laboratoire de Génétique et Biologie des Cancers, Institut Curie, Paris, France.; SIREDO: Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer, Institut Curie, Paris, France.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2019 Nov 15; Vol. 145 (10), pp. 2781-2791. Date of Electronic Publication: 2019 May 31.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Journal Info :
Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int. J. Cancer Subsets: MEDLINE
MeSH Terms :
Carcinogenesis/*genetics
Chromatin Assembly and Disassembly/*genetics
DNA Helicases/*genetics
Neuroblastoma/*genetics
Nuclear Proteins/*genetics
Transcription Factors/*genetics
Adolescent ; Case-Control Studies ; Child ; Child, Preschool ; DNA Copy Number Variations ; Exons/genetics ; Female ; Germ-Line Mutation ; Humans ; INDEL Mutation ; Infant ; Infant, Newborn ; Kaplan-Meier Estimate ; Male ; Neuroblastoma/mortality ; Neuroblastoma/pathology ; Polymorphism, Single Nucleotide ; Progression-Free Survival ; Whole Exome Sequencing ; X-linked Nuclear Protein/genetics
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies